Unknown

Dataset Information

0

A potent and highly specific FN3 monobody inhibitor of the Abl SH2 domain.

ABSTRACT: Interactions between Src homology 2 (SH2) domains and phosphotyrosine sites regulate tyrosine kinase signaling networks. Selective perturbation of these interactions is challenging due to the high homology among the 120 human SH2 domains. Using an improved phage-display selection system, we generated a small antibody mimic (or 'monobody'), termed HA4, that bound to the Abelson (Abl) kinase SH2 domain with low nanomolar affinity. SH2 protein microarray analysis and MS of intracellular HA4 interactors showed HA4's specificity, and a crystal structure revealed how this specificity is achieved. HA4 disrupted intramolecular interactions of Abl involving the SH2 domain and potently activated the kinase in vitro. Within cells, HA4 inhibited processive phosphorylation activity of Abl and also inhibited STAT5 activation. This work provides a design guideline for highly specific and potent inhibitors of a protein interaction domain and shows their utility in mechanistic and cellular investigations.

SUBMITTER: Wojcik J 

PROVIDER: S-EPMC2926940 | biostudies-literature | 2010 Apr

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

A potent and highly specific FN3 monobody inhibitor of the Abl SH2 domain.

Wojcik John J   Hantschel Oliver O   Grebien Florian F   Kaupe Ines I   Bennett Keiryn L KL   Barkinge John J   Jones Richard B RB   Koide Akiko A   Superti-Furga Giulio G   Koide Shohei S  

Nature structural & molecular biology 20100328 4

Interactions between Src homology 2 (SH2) domains and phosphotyrosine sites regulate tyrosine kinase signaling networks. Selective perturbation of these interactions is challenging due to the high homology among the 120 human SH2 domains. Using an improved phage-display selection system, we generated a small antibody mimic (or 'monobody'), termed HA4, that bound to the Abelson (Abl) kinase SH2 domain with low nanomolar affinity. SH2 protein microarray analysis and MS of intracellular HA4 interac  ...[more]

Similar Datasets

Unknown Dissection of the BCR-ABL signaling network using highly specific monobody inhibitors to the SHP2 SH2 domains.
| S-EPMC3773763 | biostudies-literature
Unknown Directed Evolution of a Highly Specific FN3 Monobody to the SH3 Domain of Human Lyn Tyrosine Kinase.
| S-EPMC4701441 | biostudies-literature
Unknown Phosphoinositide, phosphopeptide and pyridone interactions of the Abl SH2 domain.
| S-EPMC2610419 | biostudies-literature
Unknown Allosteric Inhibition of Bcr-Abl Kinase by High Affinity Monobody Inhibitors Directed to the Src Homology 2 (SH2)-Kinase Interface.
| S-EPMC4861451 | biostudies-literature
Unknown Explaining why Gleevec is a specific and potent inhibitor of Abl kinase.
| S-EPMC3562763 | biostudies-literature
Unknown SH2 domain protein E (SHE) and ABL signaling regulate blood vessel size.
| S-EPMC10349984 | biostudies-literature
Unknown Crystal structure of an SH2-kinase construct of c-Abl and effect of the SH2 domain on kinase activity.
| S-EPMC5936049 | biostudies-literature
Unknown BCR-ABL SH3-SH2 domain mutations in chronic myeloid leukemia patients on imatinib.
| S-EPMC2995357 | biostudies-literature
Unknown The Abl SH2-kinase linker naturally adopts a conformation competent for SH3 domain binding.
| S-EPMC2203333 | biostudies-literature
Unknown Synthesis of the l- and d-SH2 domain of the leukaemia oncogene Bcr-Abl.
| S-EPMC9347351 | biostudies-literature